HANUS J. GROSZ, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In his critical review article on the current status of the therapeutic applications of propranolol (1), Morrelli observes that, in addition to the three officially approved indications, clinical trials have reported the potential use of propranolol for at least 34 other disorders, among them narcotic withdrawal symptoms. The reference is an incorrect and misleading interpretation of my paper "Narcotic withdrawal symptoms in heroin users treated with propranolol" (2).
The error may have been caused by the title, which is admittedly ambiguous and can suggest two dimetrically opposite meanings: one, that the symptoms were treated with propranolol or,
GROSZ HJ. Propranolol. Ann Intern Med. 1974;80:118–119. doi: 10.7326/0003-4819-80-1-118_2
Download citation file:
Published: Ann Intern Med. 1974;80(1):118-119.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use